Nodules, nodes and non-functioning macrophages: A risk with ibrutinib therapy.
J R Coll Physicians Edinb
; 52(1): 46-47, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-36146976
We describe the case of a 70-year-old never smoker with chronic lymphocytic leukaemia, treated with single agent ibrutinib therapy. Chest imaging noted nodular change and mediastinal lymphadenopathy, which showed avid uptake on positron emission tomography and guided subsequent biopsies (bronchoscopy using endobronchial ultrasound, mediastinoscopy). Despite negative aspergillus blood immunology tests, he was found to have invasive aspergillosis, which is a known risk with ibrutinib therapy. He has since been successfully treated with antifungal therapy.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lung Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
J R Coll Physicians Edinb
Journal subject:
EDUCACAO
/
HISTORIA DA MEDICINA
/
MEDICINA
Year:
2022
Type:
Article